- Home
- AMSF vs NKTR Comparison
AMSF vs NKTR Comparison
Compare AMSF & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AMSF | NKTR |
|---|---|---|
| Founded | 1985 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Accident &Health Insurance | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 630.9M | 2.1B |
| IPO Year | 1996 | 1996 |
Fundamental Metrics
Financial Performance| Metric | AMSF | NKTR |
|---|---|---|
| Price | $32.85 | $73.27 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 6 |
| Target Price | $50.33 | ★ $129.83 |
| AVG Volume (30 Days) | 153.5K | ★ 1.1M |
| Earning Date | 05-28-2026 | 01-01-0001 |
| Dividend Yield | ★ 8.02% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 2.47 | N/A |
| Revenue | ★ $317,252,000.00 | $307,711,000.00 |
| Revenue This Year | $8.06 | N/A |
| Revenue Next Year | $6.34 | N/A |
| P/E Ratio | $13.33 | ★ N/A |
| Revenue Growth | 2.66 | ★ 86.00 |
| 52 Week Low | $32.00 | $0.43 |
| 52 Week High | $53.27 | $75.67 |
Technical Indicators
Market Signals| Indicator | AMSF | NKTR |
|---|---|---|
| Relative Strength Index (RSI) | 33.19 | 63.41 |
| Support Level | $32.00 | $52.99 |
| Resistance Level | $39.59 | $75.44 |
| Average True Range (ATR) | 1.19 | 4.13 |
| MACD | -0.20 | -0.82 |
| Stochastic Oscillator | 14.18 | 65.76 |
Price Performance
Historical ComparisonAbout AMSF AMERISAFE Inc.
AMERISAFE Inc is a specialty provider of workers' compensation insurance focused on small to mid-sized employers engaged in hazardous industries, principally construction, trucking, logging and lumber, agriculture, manufacturing, maritime, and telecommunications. The company generates a majority of its revenue in the form of premiums. The Company operates as a single reportable segment, Insurance Operations.
About NKTR Nektar Therapeutics
Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.